LUMO — Lumos Pharma Share News
0.000.00%
Last trade - 00:00- $37.41m
- $23.89m
- $2.05m
Brief: Blackstone Holdings II LP Reports 5.6% Stake In Lumos Pharma Of As Of March 18
Brief: Lumos Pharma Says Board Appointed Current CEO, Rick Hawkins, To Additional Role Of President Of Co & Chairman Of Board
Brief: Deerfield Management Company LP Reports Passive Stake In Lumos Pharma
Brief: Newlink Genetics Corp QTRLY Loss Per Share $0.22
U.S. STOCKS ON THE MOVE-Tesla, Nio, Wave Life Sciences, Franchise Group
U.S. STOCKS ON THE MOVE-Amazon, Tesla, Ulta Beauty, Spectrum Pharma
U.S. STOCKS ON THE MOVE-Tesla, Amazon, Tapestry, Qiagen
U.S. STOCKS ON THE MOVE-Spring Bank Pharmaceuticals, Microbot Medical, Qiagen, Hexo Corp
U.S. STOCKS ON THE MOVE-Boeing, Uber, Microbot Medical, Lineage Cell
U.S. STOCKS ON THE MOVE-Uber, Microbot Medical, Seadrill, Apache Corp
U.S. STOCKS ON THE MOVE-WESCO International, Soleno, NewLink Genetics, Correvio Pharma
U.S. STOCKS ON THE MOVE-NewLink Genetics, Verisign, WESCO International, Microbot Medical
NewLink Genetics: Rises on licensing deal for its cancer treatment
Brief: Newlink Genetics Announces Exclusive License Agreement With Ellipses Pharma
Merck: Hits record high after FDA approval for Ebola vaccine
Brief: NewLink Genetics Responds To Proposal From Evercel
Brief: Evercel Announces Rejected Offer To Acquire Newlink Genetics
Brief: NewLink Genetics Corp, Cyclone Merger Sub And Lumos Pharma Enter Into Amendment No.1 To Agreement And Plan Of Merger And Reorganization
Brief: Newlink Genetics Announces European Commission Grant Of Conditional Marketing Approval For Ebola Vaccine V920 (Ervebo®)